Study of ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Coronary Artery Disease
ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Patients Undergoing Percutaneous Coronary Intervention
Sponsor: Royal College of Surgeons, Ireland
Listed as NCT00905294, this observational or N/A phase trial focuses on Coronary Artery Disease and remains terminated or withdrawn. Sponsored by Royal College of Surgeons, Ireland, it has been updated 10 times since 2009, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Aug 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Royal College of Surgeons, Ireland
- University College Cork
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Cork, Ireland
- • Dublin, Ireland